"Fax: (763) 302-4345"

During the past decade, Minneapolis Clinic of Neurology, Ltd conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minneapolis Clinic of Neurology, Ltd" #1 sponsor was "Allergan" with 1 trials, followed by "Bayer" with 1 trials sponsored, "Bial - Portela C S.A." with 1 trials sponsored, "MedDay Pharmaceuticals SA" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minneapolis Clinic of Neurology, Ltd" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator, "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator, "Population Health Research Institute" with 1 trials as a collaborator, "Sunovion" with 1 trials as a collaborator and "Takeda Pharmaceuticals North America, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Minneapolis Clinic of Neurology, Ltd" are "Acute Ischemic Stroke" (1 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials), "Diabetes" (1 trials), "Epilepsies, Partial" (1 trials) and "Focal Epilepsy" (1 trials). Many other conditions were trialed in "Minneapolis Clinic of Neurology, Ltd" in a lesser frequency.

Most popular intervention types in "Minneapolis Clinic of Neurology, Ltd" are "Drug" (8 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "1200 mg QD Eslicarbazepine acetate" (1 trials), "800 mg QD Eslicarbazepine acetate" (1 trials), "BAY2433334" (1 trials) and "BAY2433334 matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Minneapolis Clinic of Neurology, Ltd" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Minneapolis Clinic of Neurology, Ltd". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Minneapolis Clinic of Neurology, Ltd, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Minneapolis Clinic of Neurology, Ltd, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Minneapolis Clinic of Neurology, Ltd has several departments that took part in Clinical trials: "Minneapolis Clinic of Neurology" - 6 trials, "The Schapiro Center for MS" - 5 trials